{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T22:06:53Z","timestamp":1768255613568,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2001,1]]},"DOI":"10.1378\/chest.119.1.185","type":"journal-article","created":{"date-parts":[[2003,6,14]],"date-time":"2003-06-14T00:09:19Z","timestamp":1055549359000},"page":"185-195","source":"Crossref","is-referenced-by-count":95,"title":["Oral Moxifloxacin vs High-Dosage Amoxicillin in the Treatment of Mild-to-Moderate, Community-Acquired, Suspected Pneumococcal Pneumonia in Adults"],"prefix":"10.1016","volume":"119","author":[{"given":"Patrick","family":"Petitpretz","sequence":"first","affiliation":[]},{"given":"Pierre","family":"Arvis","sequence":"additional","affiliation":[]},{"given":"Miroslav","family":"Marel","sequence":"additional","affiliation":[]},{"given":"Joaquim","family":"Moita","sequence":"additional","affiliation":[]},{"given":"Juan","family":"Urueta","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1378\/chest.119.1.185_bib1","first-page":"153","article-title":"An overview of community-acquired pneumonia with lessons learned from the British Thoracic Society study","volume":"9","author":"Macfarlane","year":"1994","journal-title":"Semin Respir Infect"},{"key":"10.1378\/chest.119.1.185_bib2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/clinids\/18.4.501","article-title":"Community-acquired pneumonia","volume":"18","author":"Marrie","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.119.1.185_bib3","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1164\/ajrccm\/148.5.1418","article-title":"Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity and initial antimicrobial therapy","volume":"148","author":"Niederman","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.119.1.185_bib4","first-page":"349","article-title":"Guidelines for the management of community-acquired pneumonia in adults admitted to hospital","volume":"49","author":"British Thoracic Society","year":"1993","journal-title":"Br J Hosp Med"},{"key":"10.1378\/chest.119.1.185_bib5","unstructured":"Quatri\u00e8me Conf\u00e9rence de Consensus en Th\u00e9rapeutique Anti-infectieuse, Lille, 18 Octobre 1991. Les infections des voies respiratoires. Quatri\u00e8me Conf\u00e9rence de Consensus en Th\u00e9rapeutique Anti-infectieuse de la soci\u00e9t\u00e9 de Pathologie Infectieuse de Langue Fran\u0107aise, Lille, 1991. Med Mal Infect 1992; 22, No. Special (F\u00e9vrier)"},{"key":"10.1378\/chest.119.1.185_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1155\/1993\/308589","article-title":"The Canadian community-acquired pneumonia consensus conference group","volume":"4","author":"Mandell","year":"1993","journal-title":"Can J Infect Dis"},{"key":"10.1378\/chest.119.1.185_bib7","doi-asserted-by":"crossref","first-page":"807","DOI":"10.7326\/0003-4819-121-10-199411150-00013","article-title":"Confronting drug-resistant pneumococci","volume":"121","author":"Austrian","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.119.1.185_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/clinids\/15.1.77","article-title":"Antimicrobial resistance in Streptococcus pneumoniae : an overview","volume":"15","author":"Appelbaum","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"suppl A","key":"10.1378\/chest.119.1.185_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0011-393X(96)80100-7","article-title":"Antimicrobial resistance of S pneumoniae : comparison of the in vitro activity of 16 antibiotics","volume":"57","author":"Linares","year":"1996","journal-title":"Curr Ther Res"},{"key":"10.1378\/chest.119.1.185_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/1069-417X(94)90013-2","article-title":"Penicillin-resistant S. pneumoniae on the rise in the United States: its effects on oral cephalosporins","volume":"13","author":"Yee","year":"1994","journal-title":"Antimicrob Infect Dis Newslett"},{"issue":"suppl A","key":"10.1378\/chest.119.1.185_bib11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/jac\/38.suppl_A.71","article-title":"Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae : results of a 1992\u201393 western Europe and USA collaborative surveillance study; The Alexander Project Collaborative Group","volume":"38","author":"Goldstein","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.119.1.185_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0732-8893(96)00137-X","article-title":"Highlights of the French antimicrobial resistance surveillance project","volume":"25","author":"P\u00e9an","year":"1996","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1378\/chest.119.1.185_bib13","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1001\/jama.1990.03450110084032","article-title":"Inappropriate use of oral ciprofloxacin","volume":"264","author":"Frieden","year":"1990","journal-title":"JAMA"},{"key":"10.1378\/chest.119.1.185_bib14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/jac\/42.4.523","article-title":"Comparative activity of trovafloxacin and BAY 12\u20138039 against 452 clinical isolates of Streptococcus pneumoniae","volume":"42","author":"Weiss","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.119.1.185_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0732-8893(98)00042-X","article-title":"BAY 12\u20138039, a novel fluoroquinolone activity against important respiratory tract pathogens","volume":"31","author":"Biedenbach","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"10.1378\/chest.119.1.185_bib16","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1128\/AAC.42.6.1397","article-title":"Moxifloxacin in the therapy of experimental pneumococcal meningitis","volume":"42","author":"Schmidt","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1378\/chest.119.1.185_bib17","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1128\/AAC.42.3.703","article-title":"In vitro activity of BAY 12\u20138039, a new fluoroquinolone, against mycoplasmas","volume":"42","author":"B\u00e9b\u00e9ar","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1378\/chest.119.1.185_bib18","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1128\/AAC.42.4.951","article-title":"In vitro activity of a new 8-methoxyquinolone, BAY 12\u20138039, against Chlamydia pneumoniae","volume":"42","author":"Roblin","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1378\/chest.119.1.185_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jac\/43.suppl_2.25","article-title":"In vitro activity of moxifloxacin against Legionella species and the effect of medium on susceptibility test results","volume":"43","author":"Ruckdeschel","year":"1999","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1378\/chest.119.1.185_bib20","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1128\/AAC.43.11.2793","article-title":"Pharmacokinetics of a once-daily oral dose of moxifloxacin (Bay 12\u20138039), a new enantiomerically pure 8-methoxyquinolone","volume":"43","author":"Sullivan","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1378\/chest.119.1.185_bib21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/00044011-199917050-00004","article-title":"A review of the clinical pharmacology of moxifloxacin, a new 8-methoxyquinolone, and its potential relation to therapeutic efficacy","volume":"17","author":"Wise","year":"1999","journal-title":"Clin Drug Invest"},{"key":"10.1378\/chest.119.1.185_bib22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2165\/00044011-199918010-00007","article-title":"In vitro and in vivo activity of moxifloxacin against community respiratory tract pathogens","volume":"18","author":"Blondeau","year":"1999","journal-title":"Clin Drug Invest"},{"key":"10.1378\/chest.119.1.185_bib23","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/jac\/44.6.835","article-title":"Concentrations of moxifloxacin in serum and pulmonary compartments following a single 400 mg oral dose in patients undergoing fiber-optic bronchoscopy","volume":"44","author":"Soman","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.119.1.185_bib24","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1086\/513953","article-title":"Guidelines from the Infectious Diseases Society of America: community-acquired pneumonia in adults; guidelines for management","volume":"26","author":"Bartlett","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.119.1.185_bib25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF01591354","article-title":"Early recognition of Streptococcus pneumoniae in patients with community-acquired pneumonia","volume":"15","author":"Bohte","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"10.1378\/chest.119.1.185_bib26","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1128\/AAC.36.4.833","article-title":"Efficacy and safety of temafloxacin versus those of amoxicillin in hospitalized adults with community-acquired pneumonia","volume":"36","author":"Carbon","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1378\/chest.119.1.185_bib27","first-page":"55","article-title":"Resistant pneumococci: a new threat in respiratory infections","volume":"93","author":"Goldstein","year":"1994","journal-title":"Scand J Infect Dis"},{"key":"10.1378\/chest.119.1.185_bib28","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/archinte.1993.00410110013003","article-title":"Infections due to penicillin-resistant pneumococci: clinical, epidemiologic and microbiologic features","volume":"153","author":"Capauto","year":"1993","journal-title":"Arch Intern Med"},{"issue":"sp\u00e9cial","key":"10.1378\/chest.119.1.185_bib29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0399-077X(97)80010-8","article-title":"Recommendations posologiques concernant l'amoxicilline et l'amoxicilline-acide clavulanique dans les pneumopathies communautaires de l'adulte \u00e1 l'h\u00f4pital","volume":"27","author":"Carbon","year":"1997","journal-title":"Med Mal Infect"},{"issue":"sp\u00e9cial","key":"10.1378\/chest.119.1.185_bib30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0399-077X(97)80011-X","article-title":"Mod\u00e8les exp\u00e9rimentaux d'infections \u00e1 Streptococcus pneumoniae de sensibilit\u00e9 diminu\u00e9e \u00e1 la p\u00e9nicilline G: analyze critique de l'activit\u00e9 de l'amoxicillin","volume":"27","author":"Bedos","year":"1997","journal-title":"Med Mal Infect"},{"issue":"9","key":"10.1378\/chest.119.1.185_bib31","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1128\/AAC.41.9.1965","article-title":"A multicentre randomised study comparing the efficacy and safety on intravenous and\/or oral levofloxacin versus ceftriaxone and\/or cefuroxime axetil in the treatment of adults with community-acquired pneumonia","volume":"41","author":"File","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1378\/chest.119.1.185_bib32","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1086\/516366","article-title":"Once-daily sparfloxacin versus high-dosage amoxicillin in the treatment of community-acquired, suspected pneumococcal pneumonia in adults","volume":"26","author":"Aubier","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.119.1.185_bib33","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1183\/09031936.95.08121999","article-title":"Treatment of community-acquired pneumonia: a randomised comparison of sparfloxacin, amoxycillin-clavulanic acid and erythromycin","volume":"8","author":"Lode","year":"1995","journal-title":"Eur Respir J"},{"issue":"Suppl A","key":"10.1378\/chest.119.1.185_bib34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jac\/40.suppl_1.73","article-title":"A randomised double-blind, comparative study of grepafloxacin and amoxicillin in the treatment of patients with community-acquired pneumonia","volume":"40","author":"O'deherty","year":"1997","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1378\/chest.119.1.185_bib35","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1378\/chest.110.6.1499","article-title":"Oral empiric treatment of community-acquired pneumonia: a multicenter double-blind, randomized study comparing sparfloxacin with roxithromycin","volume":"110","author":"Ortquist","year":"1996","journal-title":"Chest"},{"issue":"5","key":"10.1378\/chest.119.1.185_bib36","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0149-2918(97)80047-1","article-title":"Sparfloxacin versus cefaclor in the treatment of patients with community-acquired pneumonia; a randomised, double-masked, comparative, multicentre study","volume":"19","author":"Donovitz","year":"1997","journal-title":"Clin Ther"},{"key":"10.1378\/chest.119.1.185_bib37","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF01691581","article-title":"Trovafloxacin versus high-dose amoxicillin (1 g three times daily) in the treatment of community-acquired bacterial pneumonia","volume":"17","author":"Tr\u00e9moli\u00e8res","year":"1998","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1378\/chest.119.1.185_bib38","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1751-1097.1995.tb02392.x","article-title":"Fluoroquinolones photosensitization: a review of clinical and laboratory studies","volume":"62","author":"Ferguson","year":"1995","journal-title":"Photochem Photobiol"},{"key":"10.1378\/chest.119.1.185_bib39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF03259230","article-title":"The QT interval and drug associated torsades de pointes","volume":"5","author":"Benedict","year":"1993","journal-title":"Drug Invest"},{"issue":"Suppl A","key":"10.1378\/chest.119.1.185_bib40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jac\/37.suppl_A.161","article-title":"Overview of electrocardiographic and cardiovascular safety data for sparfloxacin","volume":"37","author":"Jaillon","year":"1996","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl A","key":"10.1378\/chest.119.1.185_bib41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jac\/40.suppl_1.83","article-title":"Safety profile of grepafloxacin compared with other fluoroquinolones","volume":"40","author":"Stahlmann","year":"1997","journal-title":"J Antimicrob Chemother"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215375838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215375838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T18:03:55Z","timestamp":1584813835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215375838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["S0012369215375838"],"URL":"https:\/\/doi.org\/10.1378\/chest.119.1.185","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}